English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

“… it is the past that is in front of us; it is the future that lies behind us.” —James DownyThe diagnosis and treatment of congenital heart disease is one of the greatest medical success stories witnessed in the latter half of the 20th century. An estimated 32 000 infants with newly diagnosed congenital cardiovascular lesions are born in the United States each year. First-year mortality rates have dropped 50% since the l960s. Currently, ≈80% of first-year survivors live to reach adulthood. By the year 2000, the estimated prevalence of adults with congenital heart disease in the United States alone is expected to approach 1 million.1 The result of converging advances in medicine, pediatrics, and cardiovascular surgery, this achievement highlights the impact of a well-crafted multidisciplinary collaborative effort. In that spirit, Perloff and Child have published …

circulation

Congenital Heart Disease in Adults Joseph K. Perloff, MD and John S. Child, MD. 406 pp. Philadelphia, Pa: WB Saunders; 1997. $110.00. ISBN 0-7216-2998-9.